PTCT

PTCT R&D Expense Growth

-14.82%Fiscal year

Period ending:

PTCT FY R&D Growth (YoY)%
PTCT FY R&D Growth (YoY)98.35%-34.20%
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

PTCT r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Ptc Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-14.8239%
-19.8155%
2.3127%
20.4948%
13.1984%
85.527%
49.6953%
46.4242%
-0.1505%
-3.4339%
52.579%
45.4903%
18.9347%
-21.3682%
0%

Compare r&d expense growth

All PTCT financial metrics · PTCT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.